eNauka - pregled

Pregled prema Projekat Roche

Prikaz rezultata 1 do 20 od 114  sledeće >
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2017A Cross-Sectional Study On Predictors Of Lung Cancer Patients Delay Time In SerbiaJovanovic, Dragana D; Perin, Branislav M; Velinovic, Milos M; Rancic, Milan H  ; Ceriman, Vesna K; Samardzic, Natalija V; Markovic, MKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2023A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient CareEl-Galaly, Tarec Christoffer; ...; Antić, Darko A.  ; ...; (broj koautora 16)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2025Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)Passiglia, Francesco; ...; Secen, Nevena; ...; (broj, koautora 36)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2016Addressing challenges for sustainable healthcare in Central and Eastern EuropeGodman, Brian; Novakovic, Tanja; Tesic, Danka; Oortwijn, Wija; Martin, Antony Paul; Parker, Mark; Haycox, AlanNaučni članak
22M22 - Međunarodni časopis kategorije M22
2025Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosisJovanovic, Dragana; Mogulkoc, Nesrin; Sterclova, Martina; Kramer, Mordechai; Muller, Veronika; Bartos, Vladimir; Plackova, Martina; Doubkova, Martina; Lewandowska, Katarzyna; Szymanowska-Narloch, Amelia;
Zurkova, Monika; Ovesna, Petra; Koziar-Vasakova, Martina;
Naučni članak
22M22 - Međunarodni časopis kategorije M22
2019Afatinib in locally advanced/metastatic NSCLC harboring common EGFR</i> mutations, after chemotherapy: a Phase IV studyThongprasert, Sumitra; Geater, Sarayut L; Clement, Dana; Abdelaziz, Amr; Reyes-Igama, Jasmin; Jovanovic, Dragana; Alexandru, Aurelia; Schenker, Michael; Sriuranpong, Virote; Serwatowski, Piotr;
Suresh, Sheethal; Cseh, Agnieszka; Gaafar, Rabab;
Naučni članak
Mp kategorija će biti prikazana naknadno.
2018Alemtuzumab and pregnancy - case series from the German MS and Pregnancy Registry, Norway and SerbiaCelius, EG; Ciplea, AI; Drulović, Jelena S. ; Thiel, S.; Gerbershagen, K.; Pekmezović, Tatjana D.  ; Viehoever, A.; Gold, Ralf; Hellwig, K.Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeSchwartz, GG; ...; Dilić, Mirza; ...; Ristić, Arsen D.  ; ...; Simić, Dragan V.  ; Ivanović, Nikola; Davidović, Goran T.  ; Tasić, Nebojša M.;
Ašanin, Milika R.  ; Stojić, Stevo; Apostolović, Svetlana R.  ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Arandjelovic, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V.  ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1390);
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2019Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaignSuppa, M; ...; Medenica, Ljiljana M; ...; (broj, koautora 38)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2021Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort CDziadziuszko, R; ...; Andric, Zoran G  ; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLCHerbst, Roy S; ...; Andric, Zoran G  ; ...; (broj, koautora 22)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2022Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trialPeters, Solange; ...; Andric, Zoran G  ; ...; (broj, koautora 26)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2019Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV RegistryCifkova, Renata; Lanska, Vera; Bruthans, Jan; Mayer, Otto Jr; Kotseva, Kornelia; Wood, David; Lovic, Dragan B  ; De, Sutter Johan; Reiner, Zeljko; Fras, Zlatko;
Deckers, Jaap; Gotcheva, Nina; Georgiev, Borislav; De, Bacquer Dirk;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2017Brain and spinal cord imaging features in neuromyelitis optica spectrum disorderCacciaguerra, Laura; Rocca, Maria Assunta; Mesaroš, Šarlota T.  ; Radaelli, Marta; Drulović, Jelena S. ; Pagani, Elisabetta; Martinelli, Vittorio; Dujmović-Bašuroski, Irena ; Comi, Giancarlo; Filippi, MassimoKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2025Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 reportButzkueven, Helmut; ...; Drulović, Jelena S. ; ...; (broj koautora 17)Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2023Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta studyBar-Or, Amit; Dufek, Michal; Budinčević, Hrvoje; Drulović, Jelena S. ; Habek, Mario; Hua, Le; Weber, Martin; Thomas, Piia; Napieralski, Julie; Clayton, David;
Kuruvilla, Denison; Qi, Qi; Xu, Yan; Goodyear, Alexandra; Oh, Jiwon;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2016Cerebrospinal fluid chitinase 3-like 1 levels in patients with radiologically isolated syndromesMatute-Blanch, Clara; ...; Drulović, Jelena S. ; ...; (broj koautora 18)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2015Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agentsKarmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2024Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyAgostinetto, Elisa; ...; Popovic, L  ; ...; (broj, koautora 42)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2020Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110Herbst, Roy S; ...; Andric, Zoran G  ; ...; (broj, koautora 21)Konferencijski rad
Mp kategorija će biti prikazana naknadno.